Experts has a new look! Let us know what you think of the updates.

Provide feedback
Home
Scholarly Works
Stereotactic ablative radiotherapy (SABR) for...
Conference

Stereotactic ablative radiotherapy (SABR) for oligoprogressive metastatic castration-resistant prostate cancer (mCRPC) during abiraterone therapy: A phase I study

Authors

Emmenegger U; Cheng S; Zukotynski K; Cheung P

Volume

28

Publisher

OXFORD UNIV PRESS

Publication Date

September 1, 2017

Name of conference

42nd European-Society-for-Medical-Oncology Congress (ESMO)

Conference place

Madrid, SPAIN

Conference start date

September 8, 2017

Conference end date

September 12, 2017

Conference proceedings

ANNALS OF ONCOLOGY

ISSN

0923-7534